ZA948908B - Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 7 infection - Google Patents

Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 7 infection

Info

Publication number
ZA948908B
ZA948908B ZA948908A ZA948908A ZA948908B ZA 948908 B ZA948908 B ZA 948908B ZA 948908 A ZA948908 A ZA 948908A ZA 948908 A ZA948908 A ZA 948908A ZA 948908 B ZA948908 B ZA 948908B
Authority
ZA
South Africa
Prior art keywords
infection
treatment
phylaxis
pro
herpes virus
Prior art date
Application number
ZA948908A
Other languages
English (en)
Inventor
Richard Anthony Vere Hodge
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA948908B publication Critical patent/ZA948908B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA948908A 1993-11-12 1994-11-10 Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 7 infection ZA948908B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939323404A GB9323404D0 (en) 1993-11-12 1993-11-12 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ZA948908B true ZA948908B (en) 1995-08-17

Family

ID=10745092

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948908A ZA948908B (en) 1993-11-12 1994-11-10 Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 7 infection

Country Status (18)

Country Link
US (1) US6051579A (es)
EP (1) EP0728002B1 (es)
JP (1) JP3821840B2 (es)
KR (1) KR100341736B1 (es)
CN (1) CN1071572C (es)
AT (1) ATE210445T1 (es)
AU (1) AU696833B2 (es)
CA (1) CA2176392C (es)
CY (1) CY2337B1 (es)
DE (1) DE69429447T2 (es)
DK (1) DK0728002T3 (es)
ES (1) ES2169117T3 (es)
GB (1) GB9323404D0 (es)
HK (1) HK1012234A1 (es)
PT (1) PT728002E (es)
SI (1) SI0728002T1 (es)
WO (1) WO1995013074A1 (es)
ZA (1) ZA948908B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475253B2 (en) 1996-09-11 2002-11-05 3M Innovative Properties Company Abrasive article and method of making
EP1532151A2 (en) * 2002-08-26 2005-05-25 Teva Pharmaceutical Industries Limited Crystalline solid famciclovir forms i, ii, iii and preparation thereof
CA2621917A1 (en) * 2005-09-08 2007-03-15 The Research Foundation For Microbial Diseases Of Osaka University Promoter for introducing gene into lymphocyte or blood cell and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US4795799A (en) * 1987-09-08 1989-01-03 Phillips Petroleum Company Production of aromatic sulfide/ketone polymers with alkali metal carbonate
CA2042931A1 (en) * 1990-05-24 1991-11-25 Robert Zahler Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
CN1136277A (zh) 1996-11-20
HK1012234A1 (en) 1999-07-30
JPH09511218A (ja) 1997-11-11
JP3821840B2 (ja) 2006-09-13
CA2176392C (en) 2005-11-08
AU696833B2 (en) 1998-09-17
US6051579A (en) 2000-04-18
WO1995013074A1 (en) 1995-05-18
ES2169117T3 (es) 2002-07-01
CY2337B1 (en) 2004-02-06
GB9323404D0 (en) 1994-01-05
CA2176392A1 (en) 1995-05-18
EP0728002A1 (en) 1996-08-28
DK0728002T3 (da) 2002-04-08
AU8149194A (en) 1995-05-29
ATE210445T1 (de) 2001-12-15
SI0728002T1 (en) 2002-04-30
EP0728002B1 (en) 2001-12-12
CN1071572C (zh) 2001-09-26
PT728002E (pt) 2002-05-31
KR100341736B1 (ko) 2002-11-23
DE69429447D1 (de) 2002-01-24
DE69429447T2 (de) 2002-07-25

Similar Documents

Publication Publication Date Title
HK1082684A1 (en) Use of B-D-dioxolanyl nucleosides in the manufacturing pharmaceuticals
HUT53522A (en) Process for producing pharmaceutical compositions comprising purine derivatives
ZA948908B (en) Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 7 infection
CY2525B1 (en) Use of penciclovir for the treatment of human herpes-virus-8
ZA948907B (en) Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 6 infections
CA2207503A1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia